VC  MBX Capital

https://www.mbxcapital.com/





     Office Locations:

2093 Philadelphia Pike #8808
Claymont, DE 19703

 

Stages:

  • Early
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    MBX Capital invests in Seed through Series B healthcare and life sciences companies. Target sectors include: Healthcare Services, Healthcare Technology, Insurance/Managed Care, Biotechnology, Pharmaceuticals, Medical Devices, Diagnostics, Research Tools, and Consumer Health. Early-stage checks are usually between $1 to $2,500,000, though with MBX's limited partners, the firm has the capacity to invest up to $30,000,000 in later stage rounds. MBX primarily invests in the United States and Canada, but is open to partnering with companies anywhere in the world.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Gurdane Bhutani Managing Partner
    Martin Gargaros Director
    Zeshan Muhammedi Managing Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      02/06/2025


      Tidal Vision


      WA


      $140,000,000


      Series B


     

    Portfolio companies include:


      Arine


      Attivare Tx


      Brightside


      CareRev


      CloudCath


      Dezy


      Earli


      Forum


      Freedom Bio


      Journey Colab


      Koneksa


      Lucy


      Luna


      Mae
        web link


      Mightier


      Osmosis


      Path CCM


      Thesis


      Tidal Vision
        web link


      Vaxxinity


      Vital Bio


      Vivodyne


     

    Recent News: